dgac384.pdf (220.99 kB)
Download fileRisk of Diabetes Following COVID-19: Translating Evidence Into Clinical and Public Health Actions
journal contribution
posted on 2022-08-05, 09:23 authored by Francesco Zaccardi, Kamlesh KhuntiOver the course of the COVID-19 pandemic, epidemiological investigations have explored the risk of various medical conditions following the acute phase of the COVID-19 infection. Although variable definitions and terms have been proposed, this cluster of conditions—encompassing mental health, neurological, metabolic, cardiorespiratory, gastrointestinal, musculoskeletal, coagulative, renal, and dermatological disorders—is commonly referred to as “post-acute sequelae of SARS-CoV-2 infection” or “long-COVID” syndrome (1).
Funding
National Institute for Health Research (NIHR) – Applied Research Collaboration (ARC) East Midlands
History
Author affiliation
Leicester Real World Evidence Unit, Diabetes Research Centre, University of LeicesterVersion
- VoR (Version of Record)